Title : APG990, a monoclonal antibody targeting OX40L, demonstrates safety and an extended half-life in healthy subjects (P3237) Presenter : Carl Dambkowski, M.D., Chief Medical Officer, Apogee ...

A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies ...

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, will present initial data at their 10 ...

The iX3 is the first offshoot of the New Class, which offers generous ranges and ample charging power. BMW is also trying to revolutionize operation.

A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced the presentation of early efficacy and ...

The iX3 is the first offshoot of the New Class, which offers generous ranges and ample charging power. BMW is also trying to ...

Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly ...

SAN FRANCISCO — AT&T agreed to pay a total of $177 million to settle a class action lawsuit about two "data incidents" from 2024. The incidents resulted in some customer data, including names, ...

If you were a Facebook user at some point in the past 15 years, you may be receiving a payment from the popular social media ...

As of Monday, Sept. 8, the incoming kindergarten class is 110 students, including 33 at Lincoln Elementary School, 30 at Roosevelt, 29 at Gussner and 18 at Louis L’Amour. The enrollment numbers are ...